| 0 |
DRUG INEFFECTIVE |
8 |
| 1 |
COUGH |
4 |
| 2 |
DEEP VEIN THROMBOSIS |
4 |
| 3 |
FATIGUE |
4 |
| 4 |
OFF LABEL USE |
4 |
| 5 |
PRODUCT SUBSTITUTION ISSUE |
4 |
| 6 |
PSORIASIS |
4 |
| 7 |
CONDITION AGGRAVATED |
3 |
| 8 |
CONSTIPATION |
3 |
| 9 |
DIARRHOEA |
3 |
| 10 |
FALL |
3 |
| 11 |
INTERMENSTRUAL BLEEDING |
3 |
| 12 |
MALAISE |
3 |
| 13 |
MENSTRUATION IRREGULAR |
3 |
| 14 |
METRORRHAGIA |
3 |
| 15 |
MIGRAINE |
3 |
| 16 |
PRODUCT PRESCRIBING ISSUE |
3 |
| 17 |
PULMONARY EMBOLISM |
3 |
| 18 |
ABDOMINAL PAIN |
2 |
| 19 |
ABDOMINAL PAIN UPPER |
2 |
| 20 |
BLINDNESS |
2 |
| 21 |
DEPRESSION |
2 |
| 22 |
DERMATITIS ATOPIC |
2 |
| 23 |
DRY EYE |
2 |
| 24 |
EMBOLISM VENOUS |
2 |
| 25 |
GASTRIC DISORDER |
2 |
| 26 |
HEADACHE |
2 |
| 27 |
HOSPITALISATION |
2 |
| 28 |
HYPERSENSITIVITY |
2 |
| 29 |
HYPOAESTHESIA |
2 |
| 30 |
INJECTION SITE PAIN |
2 |
| 31 |
INSOMNIA |
2 |
| 32 |
MUSCLE SPASMS |
2 |
| 33 |
NAUSEA |
2 |
| 34 |
NO ADVERSE EVENT |
2 |
| 35 |
PAIN |
2 |
| 36 |
PNEUMONIA |
2 |
| 37 |
PRODUCT DOSE OMISSION |
2 |
| 38 |
PRODUCT QUALITY ISSUE |
2 |
| 39 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
| 40 |
PRURITUS |
2 |
| 41 |
PSORIATIC ARTHROPATHY |
2 |
| 42 |
SEIZURE |
2 |
| 43 |
SINUSITIS |
2 |
| 44 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
| 45 |
VOMITING |
2 |
| 46 |
WEIGHT INCREASED |
2 |
| 47 |
ABDOMINAL DISCOMFORT |
1 |
| 48 |
ACNE |
1 |
| 49 |
AGE-RELATED MACULAR DEGENERATION |
1 |
| 50 |
AGGRESSION |
1 |
| 51 |
AMENORRHOEA |
1 |
| 52 |
ANAEMIA |
1 |
| 53 |
APNOEA |
1 |
| 54 |
APPENDICECTOMY |
1 |
| 55 |
ARTHRALGIA |
1 |
| 56 |
ATRIAL FIBRILLATION |
1 |
| 57 |
BACK PAIN |
1 |
| 58 |
BLOOD CHOLESTEROL INCREASED |
1 |
| 59 |
BLOOD COUNT ABNORMAL |
1 |
| 60 |
BLOOD GLUCOSE INCREASED |
1 |
| 61 |
BRONCHITIS |
1 |
| 62 |
CENTRAL NERVOUS SYSTEM LESION |
1 |
| 63 |
CEREBRAL INFARCTION |
1 |
| 64 |
CHEST PAIN |
1 |
| 65 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
| 66 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
| 67 |
CONTUSION |
1 |
| 68 |
COVID-19 |
1 |
| 69 |
CROHN^S DISEASE |
1 |
| 70 |
CYSTIC FIBROSIS |
1 |
| 71 |
DEATH |
1 |
| 72 |
DISABILITY |
1 |
| 73 |
DISEASE RECURRENCE |
1 |
| 74 |
DRUG DISPENSING ERROR |
1 |
| 75 |
DYSARTHRIA |
1 |
| 76 |
DYSPNOEA |
1 |
| 77 |
EXTRA DOSE ADMINISTERED |
1 |
| 78 |
FACIAL PARALYSIS |
1 |
| 79 |
FEELING ABNORMAL |
1 |
| 80 |
FEMUR FRACTURE |
1 |
| 81 |
FIBROMYALGIA |
1 |
| 82 |
FLUSHING |
1 |
| 83 |
FURUNCLE |
1 |
| 84 |
GASTROINTESTINAL DISORDER |
1 |
| 85 |
GASTROINTESTINAL INFLAMMATION |
1 |
| 86 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
| 87 |
GUTTATE PSORIASIS |
1 |
| 88 |
HAEMORRHOIDS |
1 |
| 89 |
HEART RATE DECREASED |
1 |
| 90 |
HEART RATE INCREASED |
1 |
| 91 |
HERNIA |
1 |
| 92 |
HIP SURGERY |
1 |
| 93 |
HYPERHIDROSIS |
1 |
| 94 |
ILLNESS |
1 |
| 95 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
| 96 |
INCORRECT DOSE ADMINISTERED |
1 |
| 97 |
INCREASED APPETITE |
1 |
| 98 |
INFLAMMATORY BOWEL DISEASE |
1 |
| 99 |
INJECTION SITE BRUISING |
1 |
| 100 |
INJECTION SITE ERYTHEMA |
1 |
| 101 |
INJECTION SITE PRURITUS |
1 |
| 102 |
INJECTION SITE SWELLING |
1 |
| 103 |
INTENTIONAL PRODUCT MISUSE |
1 |
| 104 |
JOINT RANGE OF MOTION DECREASED |
1 |
| 105 |
KIDNEY INFECTION |
1 |
| 106 |
LIMB DISCOMFORT |
1 |
| 107 |
LYMPHOEDEMA |
1 |
| 108 |
MACULOPATHY |
1 |
| 109 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
| 110 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
| 111 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
| 112 |
MICTURITION URGENCY |
1 |
| 113 |
MOBILITY DECREASED |
1 |
| 114 |
MOOD ALTERED |
1 |
| 115 |
MULTIPLE ALLERGIES |
1 |
| 116 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
| 117 |
MUSCULOSKELETAL STIFFNESS |
1 |
| 118 |
NEUTROPENIA |
1 |
| 119 |
OROPHARYNGEAL PAIN |
1 |
| 120 |
PALPITATIONS |
1 |
| 121 |
PANIC REACTION |
1 |
| 122 |
PARADOXICAL EMBOLISM |
1 |
| 123 |
PARAESTHESIA |
1 |
| 124 |
PELVIC VENOUS THROMBOSIS |
1 |
| 125 |
PERIPHERAL ARTERY OCCLUSION |
1 |
| 126 |
PERIPHERAL ISCHAEMIA |
1 |
| 127 |
PERITONSILLAR ABSCESS |
1 |
| 128 |
PHARYNGEAL OEDEMA |
1 |
| 129 |
PHOTOPHOBIA |
1 |
| 130 |
PHOTOSENSITIVITY REACTION |
1 |
| 131 |
PLEURISY |
1 |
| 132 |
POOR QUALITY PRODUCT ADMINISTERED |
1 |
| 133 |
PRE-EXISTING CONDITION IMPROVED |
1 |
| 134 |
PREGNANCY ON CONTRACEPTIVE |
1 |
| 135 |
PREGNANCY ON ORAL CONTRACEPTIVE |
1 |
| 136 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
| 137 |
PRODUCT BLISTER PACKAGING ISSUE |
1 |
| 138 |
PRODUCT DOSE OMISSION ISSUE |
1 |
| 139 |
PRODUCT USE ISSUE |
1 |
| 140 |
RASH |
1 |
| 141 |
RASH GENERALISED |
1 |
| 142 |
RESPIRATION ABNORMAL |
1 |
| 143 |
RETINAL DYSTROPHY |
1 |
| 144 |
SKIN BURNING SENSATION |
1 |
| 145 |
SKIN FISSURES |
1 |
| 146 |
SLEEP APNOEA SYNDROME |
1 |
| 147 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
1 |
| 148 |
SLEEP-RELATED EATING DISORDER |
1 |
| 149 |
SOMNAMBULISM |
1 |
| 150 |
SOMNOLENCE |
1 |
| 151 |
STAPHYLOCOCCAL INFECTION |
1 |
| 152 |
STILL^S DISEASE |
1 |
| 153 |
STREPTOCOCCAL INFECTION |
1 |
| 154 |
TACHYCARDIA |
1 |
| 155 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
| 156 |
THINKING ABNORMAL |
1 |
| 157 |
TINNITUS |
1 |
| 158 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
| 159 |
URINARY TRACT INFECTION |
1 |
| 160 |
VISION BLURRED |
1 |
| 161 |
VISUAL ACUITY REDUCED |
1 |
| 162 |
VITAMIN D DEFICIENCY |
1 |
| 163 |
WEIGHT DECREASED |
1 |
| 164 |
WHEEZING |
1 |
| 165 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |